162 related articles for article (PubMed ID: 31836741)
1. MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin.
Patil SL; Palat A; Pan Y; Rajapakshe K; Mirchandani R; Bondesson M; Yustein JT; Coarfa C; Gunaratne PH
Sci Rep; 2019 Dec; 9(1):19089. PubMed ID: 31836741
[TBL] [Abstract][Full Text] [Related]
2. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
Dai J; Lu L; Kang L; Zhang J
Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
4. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.
Dong L; Qu F
J Mol Histol; 2020 Aug; 51(4):329-340. PubMed ID: 32472335
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
Liu J; Chen M; Ma L; Dang X; Du G
Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
[TBL] [Abstract][Full Text] [Related]
6. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X
Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.
Geng S; Gu L; Ju F; Zhang H; Wang Y; Tang H; Bi Z; Yang C
J Cell Mol Med; 2016 Sep; 20(9):1611-9. PubMed ID: 27222381
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.
Yu WC; Chen HH; Qu YY; Xu CW; Yang C; Liu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221814
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7.
Hou Y; Feng H; Jiao J; Qian L; Sun B; Chen P; Li Q; Liang Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2065-2071. PubMed ID: 31126193
[No Abstract] [Full Text] [Related]
11. miR-874-3p inhibits cell migration through targeting RGS4 in osteosarcoma.
Liu WG; Zhuo L; Lu Y; Wang L; Ji YX; Guo Q
J Gene Med; 2020 Sep; 22(9):e3213. PubMed ID: 32386256
[TBL] [Abstract][Full Text] [Related]
12. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma.
Xie W; Xiao J; Wang T; Zhang D; Li Z
J Cell Mol Med; 2019 May; 23(5):3293-3301. PubMed ID: 30773847
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells.
Zhang J; Hou W; Chai M; Zhao H; Jia J; Sun X; Zhao B; Wang R
Biochem Biophys Res Commun; 2016 Jan; 469(4):1006-11. PubMed ID: 26707641
[TBL] [Abstract][Full Text] [Related]
15. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.
Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545
[TBL] [Abstract][Full Text] [Related]
16. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
19. Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma.
Li Q; Wang X; Jiang N; Xie X; Liu N; Liu J; Shen J; Peng T
Cancer Med; 2020 Sep; 9(17):6354-6366. PubMed ID: 32673448
[TBL] [Abstract][Full Text] [Related]
20. MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
Wang F; Yu D; Liu Z; Wang R; Xu Y; Cui H; Zhao T
Technol Cancer Res Treat; 2016 Dec; 15(6):NP105-NP112. PubMed ID: 26744308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
